Protection of study subjects
Executive Summary
FDA issues a draft guidance specifying the responsibilities investigators have to protect the rights and safety of patients participating in clinical trials. FDA says the agency became increasingly aware that current guidance and regulation - codified primarily in the 1970s - did not adequately address the increasing complexity of the modern clinical enterprise, including outsourcing. Comments are due by July 9...